期刊文献+

甲状腺肿瘤细胞增殖细胞核抗原、bcl-2及c-myc的表达和DNA倍体 被引量:3

Expressions of proliferating cell nuclear antigen, bcl-2 and c-myc proteins, and DNA ploidy in thyroid tumor cells
原文传递
导出
摘要 目的研究增殖细胞核抗原(PCNA)、bcl2及cmyc在甲状腺肿瘤细胞中的表达,并探讨DNA倍体数在甲状腺恶性肿瘤中的诊断价值。方法应用免疫组化技术检测36例甲状腺腺瘤和37例甲状腺腺癌标本PCNA、bcl2及cmyc的表达;并用图像分析技术测定8例甲状腺腺瘤和17例甲状腺腺癌标本的DNA倍体。结果甲状腺腺癌中PCNA阳性率为(43.02±31.16)%,cmyc的阳性表达率为89.2%,均显著高于甲状腺腺瘤(16.15±9.28)%和50.0%(均P<0.05)。而甲状腺腺癌bcl2阳性表达率为64.9%,显著低于甲状腺腺瘤88.9%(P<0.05)。甲状腺腺癌转移的淋巴结中PCNA高于其原发灶,且无bcl2表达。PCNA与bcl2及cmyc在甲状腺肿瘤中无显著相关性。甲状腺腺癌的5倍体细胞百分比显著高于甲状腺腺瘤(P<0.01)。结论bcl2及cmyc可能共同参与甲状腺腺癌的发生发展;PCNA与bcl2的异常表达可能对甲状腺肿瘤的生物学行为及预后的判断有一定参考意义。5倍体细胞大于8%可作为判断甲状腺肿瘤良恶性的参考指标。 Objective To investigate the expressions of proliferating cell nuclear antigen (PCNA), bcl-2, and c-myc protein, and to explore diagnostic value of DNA ploidy in benign and malignant thyroid neoplasms. Methods The expressions of PCNA, bcl-2 and c-myc proteins in 36 cases of thyroid adenomas and 37 cases of thyroid carcinomas were examined by immunohistochemistry technique. DNA ploidy was measured by imaging analysis technique in 8 cases of thyroid adenomas and 17 cases of thyroid carcinomas. Results Among thyroid carcinomas, the positive rates of PCNA (43.02±31.16)% and c-myc protein 89.2% were significantly higher than those of thyroid adenomas (16.15±9.28)% and 50.0% respectively (both P<0.05). Positive rate of bcl-2 in thyroid carcinoma was significantly lower than that of thyorid adenomas 64.9% vs 88.9%, (P<0.05). The positive rate of PCNA in lymph node with metastasis of thyroid carcinoma was higher than that of primitive carcinoma but bcl-2 protein was negative. There were no correlations among PCNA, bcl-2, and c-myc in thyroid neoplasm. The difference in percentages of 5-ploid cells between thyroid adenoma and thyroid carcinoma was statistically significant (P<0.01). Conclusion Both bcl-2 and c-myc proteins may play important roles in the occurrence and development of thyroid carcinoma. PCNA and bcl-2 assessments may be helpful in predicting biological behavior and prognosis of thyroid neoplasm. More than 8% of 5-ploid cells may be a reference index for identifying benign and malignant thyroid neoplasms.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2004年第4期289-292,共4页 Chinese Journal of Endocrinology and Metabolism
基金 贵州省科委资助项目(983055)
关键词 BCL-2 C-MYC 甲状腺肿瘤 腺癌 PCNA 甲状腺腺瘤 DNA倍体 体细胞 表达 标本 Thyroid neoplasms Gene Proliferating cell nuclear antigen bcl-2 c-myc Ploidies
  • 相关文献

参考文献10

  • 1Evan G, Littlewood T. A matter of life and cell death. Science, 1998,281:1317-1322.
  • 2McDonnell TJ,Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature, 1991, 349:254-260.
  • 3Bissonnet RP, Echeverri F, Mahboubi A, et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature, 1992,359:552-554.
  • 4Fontanini G, Pingitore R, Bigini E, et al. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labelling and DNA flow cytometry data. Am J Pathol, 1992,141:1285-1290.
  • 5Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apopotosis. Immunol Today, 1997,18:44-51.
  • 6Evan GL, Wyllie AH, Gibert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 1992,69:119-128.
  • 7Sambade C, Sallstrom J, Wiklund F, et al. A novel human B-cell line(u-2904)bearing t(18;14)and t(14;18)translocation. Int J Cancer, 1995,63:710-715.
  • 8August LJ, Masood S, Westerband A, et al. Oncogene expression in follicular neoplasms of the thyroid. Am J Surg, 1992,164:592-593.
  • 9Bottger TC. DNA image cytometry in stomach carcinoma. Cancer, 1992,70:1819-1821.
  • 10Bocking A, Ablei CT, Common HH, et al. Algarithm for a DNA-cytophotometry diagnosis and grading of malignancy. Anal Quan Cytol, 1984,6:1-3.

同被引文献36

  • 1卢秀波,安兆峰,王庆兆,殷德涛,邱新光.Survivin和c-myc在分化型甲状腺癌中的表达及临床意义[J].中华实验外科杂志,2004,21(6):705-706. 被引量:18
  • 2白耀.甲状腺恶性肿瘤诊断和治疗的热点讨论[J].中华内分泌代谢杂志,2004,20(4):283-286. 被引量:19
  • 3施秉银.重视甲状腺疾病的规范化诊断与治疗[J].中华内分泌代谢杂志,2006,22(2):99-100. 被引量:20
  • 4尚立芝,李德祥,秦俊莲.甲状腺肿瘤中肝细胞生长因子及其受体蛋白的表达研究[J].中华内分泌代谢杂志,2006,22(6):570-572. 被引量:1
  • 5Marti U, Ruchti C, Kampf J, et al. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid, 2001,11:137-145.
  • 6Kholova I, Ryska A, Ludvikova M, et al. Dipeptidyl peptidase Ⅳ (DPP Ⅳ, CD26 ): a tumor marker in cytologic and histopathologic diagnosis of lesions of the thyroid gland. Cas Lek Cesk, 2003,142 :167-171.
  • 7Pich A, Ponti R. MIB-1, Ki67 and PCNA scores and flowcytometry in intermediate grade malignant lymphomas. J Clin Pathol, 1994,47 : 18- 22.
  • 8Friess H, Wang L, Zhu Z, et al. Growth factor receptor are differentially expressed in cancer of the papilla of rater and pancreas. Ann Surg, 1999,230:767-775.
  • 9Kholova I, Ludvikova M, Ryska A, et al. Immunohistochemical detection of dipeptidyl peptidase Ⅳ ( CD 26 ) in thyroid neoplasia using biotinylated tyramine amplification. Neoplasma, 2003,50 : 159-164.
  • 10Aratake Y, Umeki K, Kiyoyama K, et al. Diagnostic utility of galectin- 3 and CD26 /DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol, 2002,26 : 366 -372.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部